Moreover, in female ankylosing spondylitis patients, inflammatory KDM6A expression in Th17 cells correlates with increased transcriptional ratios of immune-regulatory KDM5C, suggesting potential targets for T cell-driven therapies in autoimmune diseases [65]. Here, KDM6A is linked to autoimmune disease.